trending Market Intelligence /marketintelligence/en/news-insights/trending/0o0l5abxvgkdikyyjd4npg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Bionik Laboratories stockholders approve reverse stock split

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Blog

COVID-19 Impact & Recovery: Investment Banking


Bionik Laboratories stockholders approve reverse stock split

Bionik Laboratories Corp. said a majority of its voting capital stockholders approved a reverse split of the company's common stock at a ratio of up to 1 for 150.

The Toronto-based robotics company said it received consent from stockholders, representing about 58.57% of its outstanding shares of voting capital stock, for the reverse stock split.

The board had approved the reverse stock split in July.